 | • レポートコード：GIR-105X13712 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ホスホジエステラーゼ（PDE）阻害剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ホスホジエステラーゼ（PDE）阻害剤の種類別市場規模（PDE1選択的阻害剤、PDE2選択的阻害剤、PDE3選択的阻害剤、PDE4選択的阻害剤、PDE5選択的阻害剤、PDE7選択的阻害剤、PDE10選択的阻害剤）、用途別市場規模（経口、局所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ホスホジエステラーゼ（PDE）阻害剤の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bayer AG、Eli Lilly and Co.、GlaxoSmithKline Plc、Pfizer Inc.、Vivus Inc. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：PDE1選択的阻害剤、PDE2選択的阻害剤、PDE3選択的阻害剤、PDE4選択的阻害剤、PDE5選択的阻害剤、PDE7選択的阻害剤、PDE10選択的阻害剤 ・用途別分析2016年-2026年：経口、局所、その他 ・ホスホジエステラーゼ（PDE）阻害剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ホスホジエステラーゼ（PDE）阻害剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ホスホジエステラーゼ（PDE）阻害剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ホスホジエステラーゼ（PDE）阻害剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ホスホジエステラーゼ（PDE）阻害剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Phosphodiesterase (PDE) inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Phosphodiesterase (PDE) inhibitors size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Phosphodiesterase (PDE) inhibitors market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Phosphodiesterase (PDE) inhibitors market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
PDE1 Selective Inhibitors
PDE2 Selective Inhibitors
PDE3 Selective Inhibitors
PDE4 selective inhibitors
PDE5 selective inhibitors
PDE7 selective inhibitors
PDE10 selective inhibitors
Market segment by Application can be divided into
Oral
Topical
Other
The key market players for global Phosphodiesterase (PDE) inhibitors market are listed below:
Bayer AG
Eli Lilly and Co.
GlaxoSmithKline Plc
Pfizer Inc.
Vivus Inc.
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Phosphodiesterase (PDE) inhibitors Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Phosphodiesterase (PDE) inhibitors Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 PDE1 Selective Inhibitors
1.2.3 PDE2 Selective Inhibitors
1.2.4 PDE3 Selective Inhibitors
1.2.5 PDE4 selective inhibitors
1.2.6 PDE5 selective inhibitors
1.2.7 PDE7 selective inhibitors
1.2.8 PDE10 selective inhibitors
1.3 Market Analysis by Application
1.3.1 Overview: Global Phosphodiesterase (PDE) inhibitors Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Oral
1.3.3 Topical
1.3.4 Other
1.4 Global Phosphodiesterase (PDE) inhibitors Market Size & Forecast
1.4.1 Global Phosphodiesterase (PDE) inhibitors Sales in Value (2016-2026))
1.4.2 Global Phosphodiesterase (PDE) inhibitors Sales in Volume (2016-2026)
1.4.3 Global Phosphodiesterase (PDE) inhibitors Price by Type (2016-2026) & (USD/Liter)
1.5 Global Phosphodiesterase (PDE) inhibitors Production Capacity Analysis
1.5.1 Global Phosphodiesterase (PDE) inhibitors Total Production Capacity (2016-2026)
1.5.2 Global Phosphodiesterase (PDE) inhibitors Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Phosphodiesterase (PDE) inhibitors Market Drivers
1.6.2 Phosphodiesterase (PDE) inhibitors Market Restraints
1.6.3 Phosphodiesterase (PDE) inhibitors Trends Analysis
2 Manufacturers Profiles
2.1 Bayer AG
2.1.1 Bayer AG Details
2.1.2 Bayer AG Major Business
2.1.3 Bayer AG Phosphodiesterase (PDE) inhibitors Product and Services
2.1.4 Bayer AG Phosphodiesterase (PDE) inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Eli Lilly and Co.
2.2.1 Eli Lilly and Co. Details
2.2.2 Eli Lilly and Co. Major Business
2.2.3 Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Product and Services
2.2.4 Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 GlaxoSmithKline Plc
2.3.1 GlaxoSmithKline Plc Details
2.3.2 GlaxoSmithKline Plc Major Business
2.3.3 GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Product and Services
2.3.4 GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Pfizer Inc.
2.4.1 Pfizer Inc. Details
2.4.2 Pfizer Inc. Major Business
2.4.3 Pfizer Inc. Phosphodiesterase (PDE) inhibitors Product and Services
2.4.4 Pfizer Inc. Phosphodiesterase (PDE) inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Vivus Inc.
2.5.1 Vivus Inc. Details
2.5.2 Vivus Inc. Major Business
2.5.3 Vivus Inc. Phosphodiesterase (PDE) inhibitors Product and Services
2.5.4 Vivus Inc. Phosphodiesterase (PDE) inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Phosphodiesterase (PDE) inhibitors Sales by Manufacturer
3.1 Global Phosphodiesterase (PDE) inhibitors Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Phosphodiesterase (PDE) inhibitors Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Phosphodiesterase (PDE) inhibitors
3.4 Market Concentration Rate
3.4.1 Top 3 Phosphodiesterase (PDE) inhibitors Manufacturer Market Share
3.4.2 Top 6 Phosphodiesterase (PDE) inhibitors Manufacturer Market Share
3.5 Global Phosphodiesterase (PDE) inhibitors Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Phosphodiesterase (PDE) inhibitors Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Phosphodiesterase (PDE) inhibitors Market Size by Region
4.1.1 Global Phosphodiesterase (PDE) inhibitors Sales in Volume by Region (2016-2026)
4.1.2 Global Phosphodiesterase (PDE) inhibitors Revenue by Region (2016-2026)
4.2 North America Phosphodiesterase (PDE) inhibitors Revenue (2016-2026)
4.3 Europe Phosphodiesterase (PDE) inhibitors Revenue (2016-2026)
4.4 Asia-Pacific Phosphodiesterase (PDE) inhibitors Revenue (2016-2026)
4.5 South America Phosphodiesterase (PDE) inhibitors Revenue (2016-2026)
4.6 Middle East and Africa Phosphodiesterase (PDE) inhibitors Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Phosphodiesterase (PDE) inhibitors Sales in Volume by Type (2016-2026)
5.2 Global Phosphodiesterase (PDE) inhibitors Revenue by Type (2016-2026)
5.3 Global Phosphodiesterase (PDE) inhibitors Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Phosphodiesterase (PDE) inhibitors Sales in Volume by Application (2016-2026)
6.2 Global Phosphodiesterase (PDE) inhibitors Revenue by Application (2016-2026)
6.3 Global Phosphodiesterase (PDE) inhibitors Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Phosphodiesterase (PDE) inhibitors Sales by Type (2016-2026)
7.2 North America Phosphodiesterase (PDE) inhibitors Sales by Application (2016-2026)
7.3 North America Phosphodiesterase (PDE) inhibitors Market Size by Country
7.3.1 North America Phosphodiesterase (PDE) inhibitors Sales in Volume by Country (2016-2026)
7.3.2 North America Phosphodiesterase (PDE) inhibitors Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Phosphodiesterase (PDE) inhibitors Sales by Type (2016-2026)
8.2 Europe Phosphodiesterase (PDE) inhibitors Sales by Application (2016-2026)
8.3 Europe Phosphodiesterase (PDE) inhibitors Market Size by Country
8.3.1 Europe Phosphodiesterase (PDE) inhibitors Sales in Volume by Country (2016-2026)
8.3.2 Europe Phosphodiesterase (PDE) inhibitors Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales by Type (2016-2026)
9.2 Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales by Application (2016-2026)
9.3 Asia-Pacific Phosphodiesterase (PDE) inhibitors Market Size by Region
9.3.1 Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Phosphodiesterase (PDE) inhibitors Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Phosphodiesterase (PDE) inhibitors Sales by Type (2016-2026)
10.2 South America Phosphodiesterase (PDE) inhibitors Sales by Application (2016-2026)
10.3 South America Phosphodiesterase (PDE) inhibitors Market Size by Country
10.3.1 South America Phosphodiesterase (PDE) inhibitors Sales in Volume by Country (2016-2026)
10.3.2 South America Phosphodiesterase (PDE) inhibitors Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Phosphodiesterase (PDE) inhibitors Sales by Type (2016-2026)
11.2 Middle East & Africa Phosphodiesterase (PDE) inhibitors Sales by Application (2016-2026)
11.3 Middle East & Africa Phosphodiesterase (PDE) inhibitors Market Size by Country
11.3.1 Middle East & Africa Phosphodiesterase (PDE) inhibitors Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Phosphodiesterase (PDE) inhibitors Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Phosphodiesterase (PDE) inhibitors Typical Distributors
12.3 Phosphodiesterase (PDE) inhibitors Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Phosphodiesterase (PDE) inhibitors Revenue by Type, (USD Million), 2021-2026
Table 2. Global Phosphodiesterase (PDE) inhibitors Revenue by Application, (USD Million), 2021-2026
Table 3. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 4. Bayer AG Major Business
Table 5. Bayer AG Phosphodiesterase (PDE) inhibitors Product and Services
Table 6. Bayer AG Phosphodiesterase (PDE) inhibitors Sales (K Liter), Price (USD/Liter), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Eli Lilly and Co. Basic Information, Manufacturing Base and Competitors
Table 8. Eli Lilly and Co. Major Business
Table 9. Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Product and Services
Table 10. Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Sales (K Liter), Price (USD/Liter), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 12. GlaxoSmithKline Plc Major Business
Table 13. GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Product and Services
Table 14. GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Sales (K Liter), Price (USD/Liter), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Inc. Major Business
Table 17. Pfizer Inc. Phosphodiesterase (PDE) inhibitors Product and Services
Table 18. Pfizer Inc. Phosphodiesterase (PDE) inhibitors Sales (K Liter), Price (USD/Liter), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Vivus Inc. Basic Information, Manufacturing Base and Competitors
Table 20. Vivus Inc. Major Business
Table 21. Vivus Inc. Phosphodiesterase (PDE) inhibitors Product and Services
Table 22. Vivus Inc. Phosphodiesterase (PDE) inhibitors Sales (K Liter), Price (USD/Liter), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global Phosphodiesterase (PDE) inhibitors Sales by Manufacturer (2019-2021e) & (K Liter)
Table 24. Global Phosphodiesterase (PDE) inhibitors Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in Phosphodiesterase (PDE) inhibitors, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global Phosphodiesterase (PDE) inhibitors Production Capacity by Company, (K Liter): 2020 VS 2021
Table 27. Head Office and Phosphodiesterase (PDE) inhibitors Production Site of Key Manufacturer
Table 28. Global Phosphodiesterase (PDE) inhibitors Sales by Region (2016-2021e) & (K Liter)
Table 29. Global Phosphodiesterase (PDE) inhibitors Sales by Region (2021-2026) & (K Liter)
Table 30. Global Phosphodiesterase (PDE) inhibitors Revenue by Region (2016-2021e) & (USD Million)
Table 31. Global Phosphodiesterase (PDE) inhibitors Revenue by Region (2021-2026) & (USD Million)
Table 32. Global Phosphodiesterase (PDE) inhibitors Sales by Type (2016-2021e) & (K Liter)
Table 33. Global Phosphodiesterase (PDE) inhibitors Sales by Type (2021-2026) & (K Liter)
Table 34. Global Phosphodiesterase (PDE) inhibitors Revenue by Type (2016-2021e) & (USD Million)
Table 35. Global Phosphodiesterase (PDE) inhibitors Revenue by Type (2021-2026) & (USD Million)
Table 36. Global Phosphodiesterase (PDE) inhibitors Price by Type (2016-2021e) & (USD/Liter)
Table 37. Global Phosphodiesterase (PDE) inhibitors Price by Type (2021-2026) & (USD/Liter)
Table 38. Global Phosphodiesterase (PDE) inhibitors Sales by Application (2016-2021e) & (K Liter)
Table 39. Global Phosphodiesterase (PDE) inhibitors Sales by Application (2021-2026) & (K Liter)
Table 40. Global Phosphodiesterase (PDE) inhibitors Revenue by Application (2016-2021e) & (USD Million)
Table 41. Global Phosphodiesterase (PDE) inhibitors Revenue by Application (2021-2026) & (USD Million)
Table 42. Global Phosphodiesterase (PDE) inhibitors Price by Application (2016-2021e) & (USD/Liter)
Table 43. Global Phosphodiesterase (PDE) inhibitors Price by Application (2021-2026) & (USD/Liter)
Table 44. North America Phosphodiesterase (PDE) inhibitors Sales by Country (2016-2021e) & (K Liter)
Table 45. North America Phosphodiesterase (PDE) inhibitors Sales by Country (2021-2026) & (K Liter)
Table 46. North America Phosphodiesterase (PDE) inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 47. North America Phosphodiesterase (PDE) inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 48. North America Phosphodiesterase (PDE) inhibitors Sales by Type (2016-2021e) & (K Liter)
Table 49. North America Phosphodiesterase (PDE) inhibitors Sales by Type (2021-2026) & (K Liter)
Table 50. North America Phosphodiesterase (PDE) inhibitors Sales by Application (2016-2021e) & (K Liter)
Table 51. North America Phosphodiesterase (PDE) inhibitors Sales by Application (2021-2026) & (K Liter)
Table 52. Europe Phosphodiesterase (PDE) inhibitors Sales by Country (2016-2021e) & (K Liter)
Table 53. Europe Phosphodiesterase (PDE) inhibitors Sales by Country (2021-2026) & (K Liter)
Table 54. Europe Phosphodiesterase (PDE) inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 55. Europe Phosphodiesterase (PDE) inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 56. Europe Phosphodiesterase (PDE) inhibitors Sales by Type (2016-2021e) & (K Liter)
Table 57. Europe Phosphodiesterase (PDE) inhibitors Sales by Type (2021-2026) & (K Liter)
Table 58. Europe Phosphodiesterase (PDE) inhibitors Sales by Application (2016-2021e) & (K Liter)
Table 59. Europe Phosphodiesterase (PDE) inhibitors Sales by Application (2021-2026) & (K Liter)
Table 60. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales by Region (2016-2021e) & (K Liter)
Table 61. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales by Region (2021-2026) & (K Liter)
Table 62. Asia-Pacific Phosphodiesterase (PDE) inhibitors Revenue by Region (2016-2021e) & (USD Million)
Table 63. Asia-Pacific Phosphodiesterase (PDE) inhibitors Revenue by Region (2021-2026) & (USD Million)
Table 64. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales by Type (2016-2021e) & (K Liter)
Table 65. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales by Type (2021-2026) & (K Liter)
Table 66. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales by Application (2016-2021e) & (K Liter)
Table 67. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales by Application (2021-2026) & (K Liter)
Table 68. South America Phosphodiesterase (PDE) inhibitors Sales by Country (2016-2021e) & (K Liter)
Table 69. South America Phosphodiesterase (PDE) inhibitors Sales by Country (2021-2026) & (K Liter)
Table 70. South America Phosphodiesterase (PDE) inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 71. South America Phosphodiesterase (PDE) inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 72. South America Phosphodiesterase (PDE) inhibitors Sales by Type (2016-2021e) & (K Liter)
Table 73. South America Phosphodiesterase (PDE) inhibitors Sales by Type (2021-2026) & (K Liter)
Table 74. South America Phosphodiesterase (PDE) inhibitors Sales by Application (2016-2021e) & (K Liter)
Table 75. South America Phosphodiesterase (PDE) inhibitors Sales by Application (2021-2026) & (K Liter)
Table 76. Middle East & Africa Phosphodiesterase (PDE) inhibitors Sales by Country (2016-2021e) & (K Liter)
Table 77. Middle East & Africa Phosphodiesterase (PDE) inhibitors Sales by Country (2021-2026) & (K Liter)
Table 78. Middle East & Africa Phosphodiesterase (PDE) inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 79. Middle East & Africa Phosphodiesterase (PDE) inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 80. Middle East & Africa Phosphodiesterase (PDE) inhibitors Sales by Type (2016-2021e) & (K Liter)
Table 81. Middle East & Africa Phosphodiesterase (PDE) inhibitors Sales by Type (2021-2026) & (K Liter)
Table 82. Middle East & Africa Phosphodiesterase (PDE) inhibitors Sales by Application (2016-2021e) & (K Liter)
Table 83. Middle East & Africa Phosphodiesterase (PDE) inhibitors Sales by Application (2021-2026) & (K Liter)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Phosphodiesterase (PDE) inhibitors Typical Distributors
Table 87. Phosphodiesterase (PDE) inhibitors Typical Customers
List of Figures
Figure 1. Phosphodiesterase (PDE) inhibitors Picture
Figure 2. Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Type in 2020
Figure 3. PDE1 Selective Inhibitors
Figure 4. PDE2 Selective Inhibitors
Figure 5. PDE3 Selective Inhibitors
Figure 6. PDE4 selective inhibitors
Figure 7. PDE5 selective inhibitors
Figure 8. PDE7 selective inhibitors
Figure 9. PDE10 selective inhibitors
Figure 10. Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Application in 2020
Figure 11. Oral
Figure 12. Topical
Figure 13. Other
Figure 14. Global Phosphodiesterase (PDE) inhibitors Market Size, (USD Million) & (K Liter): 2020 VS 2021 VS 2026
Figure 15. Global Phosphodiesterase (PDE) inhibitors Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. United States Phosphodiesterase (PDE) inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Canada Phosphodiesterase (PDE) inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Mexico Phosphodiesterase (PDE) inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Germany Phosphodiesterase (PDE) inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. France Phosphodiesterase (PDE) inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. United Kingdom Phosphodiesterase (PDE) inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Russia Phosphodiesterase (PDE) inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Italy Phosphodiesterase (PDE) inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. China Phosphodiesterase (PDE) inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Japan Phosphodiesterase (PDE) inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Korea Phosphodiesterase (PDE) inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. India Phosphodiesterase (PDE) inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Southeast Asia Phosphodiesterase (PDE) inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Australia Phosphodiesterase (PDE) inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Brazil Phosphodiesterase (PDE) inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Egypt Phosphodiesterase (PDE) inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Saudi Arabia Phosphodiesterase (PDE) inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. South Africa Phosphodiesterase (PDE) inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Turkey Phosphodiesterase (PDE) inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Global Phosphodiesterase (PDE) inhibitors Sales (2016-2026) & (K Liter)
Figure 36. Global Phosphodiesterase (PDE) inhibitors Production Capacity (2016-2026) & (K Liter)
Figure 37. Global Phosphodiesterase (PDE) inhibitors Production Capacity by Geographic Region: 2020 VS 2021
Figure 38. Phosphodiesterase (PDE) inhibitors Market Drivers
Figure 39. Phosphodiesterase (PDE) inhibitors Market Restraints
Figure 40. Phosphodiesterase (PDE) inhibitors Market Trends
Figure 41. Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Manufacturer in 2020
Figure 42. Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Manufacturer in 2020
Figure 43. Phosphodiesterase (PDE) inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 44. Top 3 Phosphodiesterase (PDE) inhibitors Manufacturer (Revenue) Market Share in 2020
Figure 45. Top 6 Phosphodiesterase (PDE) inhibitors Manufacturer (Revenue) Market Share in 2020
Figure 46. Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Region (2016-2026)
Figure 47. Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Region (2016-2026)
Figure 48. North America Phosphodiesterase (PDE) inhibitors Revenue (2016-2026) & (USD Million)
Figure 49. Europe Phosphodiesterase (PDE) inhibitors Revenue (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Phosphodiesterase (PDE) inhibitors Revenue (2016-2026) & (USD Million)
Figure 51. South America Phosphodiesterase (PDE) inhibitors Revenue (2016-2026) & (USD Million)
Figure 52. Middle East & Africa Phosphodiesterase (PDE) inhibitors Revenue (2016-2026) & (USD Million)
Figure 53. Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2016-2026)
Figure 54. Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Type (2016-2026)
Figure 55. Global Phosphodiesterase (PDE) inhibitors Price by Type (2016-2026) & (USD/Liter)
Figure 56. Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2016-2026)
Figure 57. Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Application (2016-2026)
Figure 58. Global Phosphodiesterase (PDE) inhibitors Price by Application (2016-2026) & (USD/Liter)
Figure 59. North America Phosphodiesterase (PDE) inhibitors Sales Market Share by Country (2016-2026)
Figure 60. North America Phosphodiesterase (PDE) inhibitors Revenue Market Share by Country (2016-2026)
Figure 61. North America Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2016-2026)
Figure 62. North America Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2016-2026)
Figure 63. Europe Phosphodiesterase (PDE) inhibitors Sales Market Share by Country (2016-2026)
Figure 64. Europe Phosphodiesterase (PDE) inhibitors Revenue Market Share by Country (2016-2026)
Figure 65. Europe Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2016-2026)
Figure 66. Europe Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2016-2026)
Figure 67. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Phosphodiesterase (PDE) inhibitors Revenue Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2016-2026)
Figure 71. South America Phosphodiesterase (PDE) inhibitors Sales Market Share by Country (2016-2026)
Figure 72. South America Phosphodiesterase (PDE) inhibitors Revenue Market Share by Country (2016-2026)
Figure 73. South America Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2016-2026)
Figure 74. South America Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Phosphodiesterase (PDE) inhibitors Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Phosphodiesterase (PDE) inhibitors Revenue Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2016-2026)
Figure 78. Middle East & Africa Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2016-2026)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
TNF阻害剤の世界市場予測 2023年：メーカー別、地域別、種類・用途別 TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and causes inflammation. TNF drugs are used to reduce inflammation and stop disease progression by targeting the tumor necrosis factor, which is an inflamm…- 世界のMEK阻害剤市場 2021：企業別、地域別、種類・用途別 The MEK Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…
- 世界のヤヌスキナーゼ（JAK）阻害剤市場 2021：企業別、地域別、種類・用途別 The Janus Kinase (JAK) Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界のBRAFキナーゼ阻害剤市場 2021：企業別、地域別、種類・用途別 The BRAF Kinase Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- IDOインヒビターの世界市場予測 2023年：メーカー別、地域別、種類・用途別 The IDO (indoleamine 2,3-dioxygenase 1, IDO1, IDO-1, INDO, indoleamine-pyrrole 2,3-dioxygenase) inhibitors pipeline analysis report includes ongoing clinical and non-clinical trends in the global IDO inhibitors market. Most of the pipeline therapeutics are in early stage of development, the market i…